Related Experiment Video
Updated: Feb 6, 2026
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.8K
Satisfaction with Financial Incentives for Chronic Disease Prevention
American Journal of Health Behavior
|August 31, 2018
Summary
Medicaid enrollees were satisfied with financial incentives for chronic disease prevention programs, finding they aided health improvements. However, satisfaction varied based on incentive type, amount, and program delivery.
Area of Science:
- Public Health
- Health Services Research
- Behavioral Economics
Background:
- Financial incentives are increasingly used in public health programs.
- Understanding user satisfaction is crucial for program effectiveness.
- Medicaid enrollees represent a key population for chronic disease prevention.
Purpose of the Study:
- To evaluate Medicaid enrollees' experiences and satisfaction with financial incentive programs for chronic disease prevention.
- To identify factors influencing satisfaction with these incentive programs.
Main Methods:
- A mixed-methods approach combining 31 focus groups (N=212) and a mail survey (N=2274).
- Data collected from participants in 10 states under the Medicaid Incentives for Prevention of Chronic Diseases model.
- Qualitative and quantitative analyses to assess satisfaction and influencing factors.
Main Results:
- Overall participant satisfaction with program incentives was reported.
- Incentives were perceived by participants as helpful for making positive health changes.
- Satisfaction levels differed significantly based on incentive characteristics (form, magnitude) and program delivery.
Conclusions:
- Program and incentive design significantly impact participant satisfaction and engagement in chronic disease prevention.
- Further research is needed to optimize incentive program design for sustained behavior change.
More Related Videos
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
1.6K
04:24Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
1.1K
Related Concept Videos
01:25Chronic Kidney Disease I: Introduction
739
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
739
01:24Chronic Obstructive Pulmonary Disease
2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
01:26Coronary Artery Disease IV: Preventive Measures
699
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
699
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.6K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.6K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.8K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.2K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.2K